Corrigendum To: “The NLRP3 Inflammasome and the Emerging Role of Colchicine to Inhibit Atherosclerosis-Associated Inflammation” [Atherosclerosis. 2018 Feb;269:262–271]

Atherosclerosis - Netherlands
doi 10.1016/j.atherosclerosis.2018.03.043
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Role of NLRP3 Inflammasome in Atherosclerosis and Aortic Aneurysm

The Journal of Japanese College of Angiology
2019English

Atherosclerosis in ApoE-deficient Mice Progresses Independently of the NLRP3 Inflammasome

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2011English

Interleukin 27 Is Increased in Carotid Atherosclerosis and Promotes NLRP3 Inflammasome Activation

PLoS ONE
Multidisciplinary
2017English

Hsp90 Inhibition as a Means to Inhibit Activation of the NLRP3 Inflammasome

Scientific Reports
Multidisciplinary
2018English

From Inflammation to Calcification in Atherosclerosis

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Emerging Role of IL-17 in Atherosclerosis

Journal of Innate Immunity
AllergyImmunology
2010English

The NLRP3 Inflammasome in Pathogenic Particle and Fibre-Associated Lung Inflammation and Diseases

Particle and Fibre Toxicology
MutagenesisToxicologyHealthMedicine
2015English

New Insights Into the Role of Iron in Inflammation and Atherosclerosis

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Macrophages in Vascular Inflammation – From Atherosclerosis to Vasculitis

Autoimmunity
AllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy